EMERYVILLE, Calif.--(BUSINESS WIRE)--KineMed, Inc. (www.kinemed.com) announced today that two Chronic Lymphocytic Leukemia (CLL) studies utilizing KineMed’s proprietary kinetic biomarker technology, will be presented at the American Society of Hematology Annual Meeting taking place December 6-9, 2014 in San Francisco, California. KineMed’s CLL research collaborators, Jan A. Burger, MD, Ph.D., of the MD Anderson Cancer Center, and Elizabeth J. Murphy, MD, DPhil, from the at the University of California San Francisco Department of Medicine and representing the CLL Research Consortium investigators, will present the studies at the conference.
Help employers find you! Check out all the jobs and post your resume.
